Weekly Roundup: April 24–30, 2020


More from:

This roundup contains a collection of the posts published on the Forum during the week of April 24-30, 2020.

A Look at the Data Behind Recent Poison Pill Adoptions


The Rise of the Aggressive Poison Pill


Federal District Court Dismissal of Challenge to Board Diversity Statute



U.K. and EU Regulators Move Ahead on ESG Disclosures and Benchmarks


ISS and Glass Lewis Guidances on Poison Pills during COVID-19 Pandemic



Is Financial Globalization in Reverse after the 2008 Global Financial Crisis? Evidence from Corporate Valuations






COVID-19 and Corporate Governance: Key Issues for Public Company Directors



Stakeholder Principles in the COVID Era


Executive Compensation Considerations in PIPE Transactions


Institutional Investors’ Overboarding Policies for Directors


The Executive Pay Dilemma


More from:
Trackbacks are closed, but you can post a comment.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

  • Subscribe or Follow

  • Supported By:

  • Program on Corporate Governance Advisory Board

  • Programs Faculty & Senior Fellows